Erratum: A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation (Journal of Medicinal Chemistry (2016) 59 (1021-1031) DOI 10.1021/acs.jmedchem.5b01532)

Full text of DOI:10.1021/acs.jmedchem.6b00239

Addition/Correction
pubs.acs.org/jmc
Correction to A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay:
Substrate Screening and Inhibitor Evaluation
Iacopo Galleano, Matthias Schiedel, Manfred Jung, Andreas S. Madsen, and Christian A. Olsen*
Journal of Medicinal Chemistry 2016, 59, 1021−1031. DOI: 10.1021/acs.jmedchem.5b01532
S
* Supporting Information
Page 1030. Multiple corrections were made to the Supporting
Information file, including Scheme S1 and compound numbers.
The revised Supporting Information file is available with this
Addition/Correction and has also been uploaded with the
indicated manuscript on March 3, 2016.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.jmed-
chem.6b00239.
■
S
Michaelis−Menten plot for NAD+, synthesis of (Z)-2-
ene-, (R/S)-3-hydroxy-, and 3-oxo-carboxylic acids,
additional experimental procedures, additional com-
pound characterization data, definition of abbreviations
used, as well as copies of 1H NMR and 13C NMR spectra
(PDF)
Published: March 3, 2016
© 2016 American Chemical Society
2847
DOI: 10.1021/acs.jmedchem.6b00239
J. Med. Chem. 2016, 59, 2847−2847